Join us for two-days of interactive and on-demand sessions covering a mix of therapeutic and business development issues, as well as for chats with industry leaders and a variety of company presentations with Q&A opportunities.

Sessions will remain available on demand for a period of at least 30 days after the start of the event. 

Topics Under Consideration

  • The Next Wave of I/O Targets: KRAS, MET, STING, and Beyond
  • SPACs: Advantages and Disadvantages Versus Normal IPOs
  • U.S. Election Outlook—Presidential & Congressional Scenario Planning for Biopharma Priorities
  • How to Pivot Neurodegeneration Treatment Research?
  • Addressing Racism and Disparities during Therapeutic Development and in the Clinic
  • Exploring New Developments in Diagnostics
  • China Business Development Now: New Opportunities and Barriers
  • New Resources to Accelerate Translational Research
  • Bispecific Antibodies, Key Applications and Limitations
  • View from the Board: Managing Teams During a Pandemic 
  • The New AMR Action Fund for Derisking Co-Investment
  • Shifting Your Development Program to a COVID-19 Indication
  • Market Outlook—Solid Ground or Thin Ice?
  • AI and Digital Health’s Transformation of the Patient Experience
  • Structuring Chronic Disease Development to Increase Investor Interest
  • CRISPR’s Impact on Next Generation Gene Therapies
  • Conducting Remote Clinical Trials Productively During a Pandemic
  • Achieving Corporate Diversity and Inclusion Goals through Investment and Policy Choices
  • Negotiating Outcomes-Based Payment Models
  • BIO's State of VC Investment Trends

 

EVT-BIF19.jpg
Speakers

The 2020 roster of industry leaders who will be speaking at the event will be announced soon.

EVT-BIF19.jpg
Program Topics

Get the pulse on biotech policy and investment trends. 2020 program topics will be announced soon.

Virtual Education
Schedule of Events

Check back for a day-by-day schedule of events.

Company Presentation at BIF
Who Presents

Company presentations are an integral programming element at the BIO Investor Forum that allow companies to discuss their pipeline, R&D activities, and future goals to this exclusive audience.  

Company Presentation
Apply to Present in 2020

Company presenters tend to receive double the number of requests than non-presenters, and schedule twice as many meetings than non-presenting companies. 

BIO Spark Showcase
Participation in the BIO SPARK Showcase is free.   

The BIO SPARK Showcase aims to provide an excellent opportunity for academic researchers in the SPARK network to showcase drug development programs that are ready for partnering or venture funding.

The BIO Investor Forum is historically well attended by the venture arms and business development units of major pharmaceutical companies, smaller specialty pharma/biotech companies looking to add to their pipelines, start-ups, and many early stage venture capital firms, making it the ideal setting for early stage assets from the university setting. Academics interested in partnering will present their programs and also have one-on-one discussions with interested parties.

 

Entrepreneurship for Life Science and Healthcare Startups: Master Class Direct from Silicon Valley

The UCSF Entrepreneurship Center is offering an online, global Master Class for scientists, clinicians, entrepreneurs, entrepreneurship organizations, corporations, technology transfer offices, accelerators, incubators, governments, and others to learn about starting a new life science/healthcare venture. It will be led by Stephanie Marrus, Managing Director of the Center. The course includes lectures by Silicon Valley investors, entrepreneurs and experts, live Peer Forums and drop-ins by mentors.

View the list of Silicon Valley expert lecturers, with course details and pre-registration form.

 

 

Statement on Diversity

BIO is committed to workforce development, diversity, and inclusion, and incorporates these values into all aspects of BIO operations. Program development for BIO’s events will be considered in this light, with specific attention paid to speakers’ gender, race, ethnic background, sexual orientation, and gender identity, as well as their company’s focus, financing, geographic location, and size.  Diverse programming at BIO’s events allows BIO to remain a strong leader in efforts to ensure that the biotechnology industry can attract, develop, and retain a high-quality, globally competitive employee talent pool. Learn more about Workforce Development, Diversity, & Inclusion at BIO.  

How Will Your Company Stand Out?

We've added new sponsorship and digital advertising inventory that will showcase your company in front of an elite business development and investor audience before, during, and after the BIO Investor Forum Digital

Take a look at the new opportunities by downloading the full prospectus.

BIO Investor Forum Digital Company Visibility